INTRODUCTION
During T cell dependent (TD) immune responses, B cells undergo proliferation, differentiation, and selection in the microenvironment of the germinal center (GC), thereby leading to the formation of the memory B cell compartment. According to many models, the GC response takes place in a series of discrete stages (Kelsoe and Zheng, 1993; MacLennan, 1994; Liu and Arpin, 1997; Camacho et al., 1998) . After their antigen receptors (BCRs) engage antigen, follicular B cells migrate to near the border of T zones and undergo cognate interaction with helper T cells. Subsequently, pre-GC B cells travel to the center of the follicle and rapidly proliferate in association with follicular dendritic cells (FDCs), resulting in formation of the GC proper. It has been suggested that during this early phase of clonal expansion, changes in the structure and function of BCRs do not occur, and this results in the generation of a sufficient pool of precursors to sustain the somatic-hypermutation-selection and differentiation processes that ensue (Jacob et al., 1991) .
Histologic and flow cytometric GC ''time course'' studies have provided support for this idea (Berek et al., 1991; Jacob et al., 1991; Jacob and Kelsoe, 1992; McHeyzer-Williams et al., 1993; Camacho et al., 1998; Vora et al., 1999) , but their limited resolution has not allowed a distinction between initial B cell clonal expansion in and recruitment to the GC. Moreover, recent multiphoton imaging studies of ongoing GC reactions in lymph nodes have revealed a far greater degree of plasticity of GC B cell behavior than predicted by previous models of this response (Allen et al., 2007; Schwickert et al., 2007; Hauser et al., 2007) . In particular, these analyses demonstrated extensive migration of individual GC B cells within, around, into, and out of the GC proper.
Given the above considerations, we performed a detailed analysis of the interrelationship of proliferation, differentiation, and microenvironmental locale in homogenous populations of pre-GC B cells during the early stages of TD immune responses. These studies revealed a previously unappreciated stage of the GC B cell developmental pathway, in which pre-GC B cells undergo rapid clonal expansion at the perimeter of follicles without induction of somatic hypermutation, heavy-chain class switching, or expression of genes necessary for homing to the center of follicles. Our findings necessitate revision of previous models for the GC response.
RESULTS

V H Gene-Targeted Transgenic Mice
We utilized a previously described line of Igh locus V H genetargeted transgenic mice termed HKI65 for our studies (Heltemes-Harris et al., 2004) . B cells in these mice express a high frequency of BCRs that bind the hapten arsonate (Ars) and are encoded by a single V gene segment combination and thus are termed ''canonical.'' Such targeted V H loci efficiently undergo somatic hypermutation (SHM) and class switch recombination (CSR) (Taki et al., 1995; Shih et al., 2002) . For most experiments, HKI65 Igh +/À mice were mated to a previously described line of immunoglobulin (Ig) light (L) chain transgenic mice expressing the canonical Vk10A-Jk1 L chain gene (Liu et al., 2007) , creating double-transgenic mice we term HKI65-Vk10. Greater than 95% of B cells in these mice express canonical BCRs that are readily detected in histological and flow cytometric analyses with the anticlonotypic mAbs E4 (Notidis et al., 2002; Heltemes-Harris et al., 2004) or 5Ci (Wysocki and Sato, 1981 ; B.A., unpublished data).
HKI65-Vk10 B Cells Are Located at the Perimeter of Follicles during the Early Anti-Ars Response
Splenic B cells enriched from HKI65-Vk10 mice were injected into immunosufficient, unirradiated, nontransgenic, syngeneic recipients that had or had not been immunized intraperitoneally (i.p.) with Ars-keyhole limpet hemocyanin (Ars-KLH) in alum 1 week earlier. All recipient mice used in these studies were incapable of expressing canonical BCRs because of absence of the requisite V H gene segment. This preimmunization approach was initially taken because we anticipated that it would result in prior development of a KLH-specific helper T cell compartment sufficient to induce synchronous activation of many Ars-specific donor B cells. Such an approach would allow effective evaluation of various stages of their subsequent response to antigen in vivo. In some experiments, donor cells were labeled with CFSE to allow monitoring of cell division (Lyons and Parish, 1994) . Also, in most studies, recipient mice were strain C57BL/ 6.CD45.1 (B6.CD45.1) and as such permitted distinction of donor and host B cells with the CD45.1-CD45.2 allotype system, irrespective of the structure and expression of their BCRs. One day after transfer, donor B cells were mainly found by histological analyses to be scattered throughout follicles in unimmunized chimeric mice, a distribution that persisted for 10 days. Flow cytometric analysis at all time points after transfer did not reveal proliferation or expression of the GC activation marker GL7 by donor B cells in these mice (data not shown). B cells transferred to immunized mice were also observed in follicles on day 1. However, a major subset of these cells was concentrated at the interface of follicles and the periarteriolar lymphoid sheath (PALS) T cell zones ( Figure 1A , top row), where initial cognate interaction of antigen-specific B cells and T cells most probably takes place (Jacob et al., 1991; Liu et al., 1991; Jacob and Kelsoe, 1992; Martin and Goodnow, 2002; Pape et al., 2003) .
By day 2, staining with anti-CD45.2 ( Figure 1A ) and 5Ci (data not shown) revealed small numbers of donor B cells located at the perimeter of follicles, near the border with the marginal zone (MZ) (defined by staining of metallophillic MZ cells with the mAb MOMA1). Most donor cells in this locale were distal to the PALS ( Figure 1A , day 2). By day 3, donor B cells were numerous in this region ( Figure 1A , day 3). At day 4, donor B cells were abundant in the center of follicles ( Figure 1A , day 4). By day 5, most of these cells were located in GCs, as defined by staining with GL7 for GC B cells and FDC-M2 for FDCs ( Figure 1B ). These results suggested that canonical HKI65-Vk10 B cells were undergoing clonal expansion at the perimeter of follicles prior to entering the GC reaction.
HKI65-Vk10 B Cells Undergo Rapid Proliferation at the Perimeter of Follicles Prior to Entering GCs
To test this idea, we performed histological studies by using a mAb specific for the nuclear proliferation antigen Ki67 and flow cytometric analyses for dilution of CFSE in donor B cells. Figure 2A (day 1, top row) illustrates that only a small percentage of donor B cells present in and around the T cell zone at day 1 were Ki67 + . In marked contrast, by days 2 and 3, the majority of these B cells, now located at the perimeter of follicles, were Ki67 + ( Figure 2A , day 2 and day 3). The results of quantification of such data are presented in Figure 2B . As expected from previous studies (Camacho et al., 1998; Rahman et al., 2003) , by day 4, nearly all donor B cells, now located in GCs in the center of follicles, were Ki67 + ( Figure 2A , day 4). In addition, BrdU-pulse-labeling studies showed that anti-clonotype + B cells in the S phase were numerous in the locale of the perimeter of follicles in the day 2 to 4 time frame (data not shown). These data showed that HKI65-Vk10 B cells are actively proliferating while they are located at the follicular perimeter. Figure 3 illustrates that results entirely analogous to those obtained with the preimmunization protocol were obtained with this postimmunization approach, although donor B cell localization to and proliferation in the follicular perimeter and subsequent donor B cell entry into GCs were delayed by 1-2 days as compared to the preimmunization situation, and the response of these donor cells appeared less synchronous. We next combined CFSE labeling of donor B cells with histological and flow cytometry analyses to extend the resolution of these postimmunization protocol studies. At day 2 after immunization, donor B cells were predominantly located at the interface of the follicle and the PALS and had not undergone detectable levels of proliferation (data not shown). Figure 4A illustrates that at day 3 after immunization, donor B cells were located both at the interface of the follicles and PALS and in the follicular perimeter. Flow cytometric measurement of CFSE dilution and other markers revealed that the majority of donor B cell had not undergone proliferation at this time point (Figure 4C, . By day 4, however, most donor B cells were located at the follicular perimeter and many were Ki67 + ( Figure 4B ). Figure 4B , lower left, illustrates that all of the donor B cells located in this region lacked CFSE fluorescence, most probably because of the fact that active proliferation had diluted their levels of CFSE below the detection limit of fluorescence microscopy. Flow cytometry demonstrated that a major fraction of these cells had divided two to four times ( Figure 4C , lower panels). Figure 4C also illustrates that while proliferating, donor B cells at days 3 and 4 had begun to acquire the GL7 activation marker and expressed progressively lower amounts of surface IgD. They had not yet become PNA + and did not express detectable surface IgG. Analogous results were obtained with the preimmunization protocol ( Figure S1 available online). However, in these studies nearly all donor B cells were recruited into the proliferative response, and this response was accelerated by several days. Also, proliferating donor B cells expressed higher, very uniform amounts of the GL7 marker, intermediate amounts of PNA binding, and lower amounts of sIgD than those observed with the postimmunization protocol. A minor fraction of such cells also appeared to acquire expression of sIgG. We speculate that these differences are due to the high degree of antigenspecific T cell help available to donor B cells as they are incorporated into an already ongoing immune response.
Some B cells participating in the early stages of certain TD immune responses are destined for development into plasmablasts (Liu et al., 1991; Jacob and Kelsoe, 1992; McHeyzerWilliams et al., 1993; Smith et al., 1996; Shih et al., 2002; Pape et al., 2003) . Because such cells would not express GL7 and might only express low amounts of B220 but high amounts of the AFC marker syndecan (CD138), we also monitored the dilution of CFSE in B220 + , GL7 À , and B220 À and CD138 + donor cells in the chimeric mice. Cell division was only observed in the B220 high and CD138 À subpopulations ( Figure S1C , top panels; data not shown). Moreover, using both protocols, we did not observe many proliferating donor B cells in the blood during the time of rapid proliferation in the spleen ( Figure S2 ). Taken together with the Ki67 staining studies described above, this argues that most, if not all, of the pre-GC B cell proliferative response take place at the follicular perimeter. Finally, we also investigated the influence of canonical B cell precursor frequency on the results obtained in both protocols. For these studies, HKI65-Vk10 B cells were injected in various doses. As few as 2 3 10 4 donor B cells could be injected and subsequently endogenous L chain genes. Nonetheless, canonical B cells can be identified in these mice with the anticlonotypic E4 mAb. To investigate the possibility that localization of proliferating canonical B cells to the follicular perimeter in the studies described above was influenced by the adoptive transfer protocols, we directly immunized HKI65 Igh +/À mice with Ars-KLH in alum and performed histological analysis of the canonical B cell response in the spleen at several time points.
As expected, the canonical B cell response in this case was far less uniform and synchronous as compared to that observed with adoptive transfer protocols. Nonetheless, at day 4 after immunization, many E4 + B cells were observed at the follicle-PALS interface, and at day 5 and into day 6, this distribution had changed dramatically in that a major subpopulation of canonical B cells were now observed at the follicular perimeter ( Figure S3A ). Ki67 staining analysis showed that many of the donor B cells in this locale were proliferating (Figures S3B and S3C) . These results strongly indicated that proliferation of pre-GC B cells at the follicular perimeter is not a result of the adoptive transfer protocol used in our studies.
HKI65-Vk10 B Cells at the Perimeter of Follicles Have a Unique Developmental Gene Expression Profile
The above studies suggested that canonical B cells at the perimeter of follicles in immunized mice were intermediates between those initially activated at the T-B interface and GC B cells. We further examined this issue by analyzing the expression of
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The Site of Pre-GC B Cell Proliferation various genes required for GC and AFC development and B cell migration via Q-RT-PCR in four subpopulations of B cells purified by FACS: naive B cells from C57BL/6 mice (used as a standard) and three fractions of B cells from chimeric mice at day 3 after donor cell injection of immunized recipient mice: GL7 À , CFSE + ,
(donor B cells that had not divided), GL7 int , CFSE int (donor cells that had divided four to six times), and GL7 + , CFSE À cells (donor and host GC B cells that had divided extensively, see lower-right inset, Figure 5 ). Figures 5A and 5B illustrate that, as predicted from previous studies, GL7 + , CFSE À GC B cells expressed high levels of RNA encoding activation induced cytidine deaminase (AID) (Muramatsu et al., 1999) , IgG H chain and Bcl-6 (Onizuka et al., 1995; Cattoretti et al., 1995; Allman et al., 1996; Flenghi et al., 1996) , CXCR4 (Allen et al., 2004) , and CXCR5 as compared to naive B cells. These cells expressed moderate amounts of BLIMP-1 and nearly undetectable CCR7 RNA. In contrast, GL7
À , CFSE + donor B cells had undetectable RNA encoding AID, low amounts for IgG H chain, modest amounts for Bcl-6, BLIMP-1, and CXCR5, very low amounts for CXCR4, and high levels for CCR7. This expression profile is consistent with B cells that had recently left the interface of B and T cell zones, given that CCR7 is required for B cell migration to this locale (Reif et al., 2002; Cyster, 2005) . Cells with a GL7 int , CFSE int phenotype expressed low amounts of RNA for AID and Bcl-6, and very low to undetectable amounts of RNA for IgG, BLIMP-1, CCR7, CXCR4, and CXCR5. The low expression of RNA for the chemokine receptors indicated that these cells, predominantly located at the perimeter of follicles, were sessile. Histological analyses confirmed that few donor B cells in this locale expressed IgG at the day 3 time point (data not shown). In total, these data support the conclusion that proliferation of cells at the follicular perimeter constitutes a discrete stage in memory B cell development.
B Cell Proliferation at the Perimeter of Follicles Is Not Accompanied by Somatic Hypermutation
To further test this idea, we determined whether donor HKI65-Vk10 B cells that had undergone various numbers of divisions in the chimeric mice had activated SHM to an extent characteristic of GC B cells. B cells present in different CFSE intensity peaks were purified by FACS. The HKI65 V H locus was PCR amplified from these fractions, and the products were cloned and sequenced. No mutations were found in V H clones obtained from division peaks zero and five isolated 3 days after donor cell injection (Table S1 ). In contrast, anticlonotype + GCs microdissected from sections of spleens isolated at day 5 after donor cell transfer yielded HKI65 PCR V H clones with an average mutation frequency of 0.4%, and 30% of these mutations were found in SHM ''hotspots.'' These mutations were rather randomly distributed, and those known to increase affinity for Ars were rare (data not shown), as would be expected at this early stage of the GC reaction ( These data are consistent with those in Figure 5 showing that low and very high amounts of AID expression were apparent in donor GL7 int , CFSE int , and GL7 + , CFSE À (GC) B cells, respectively.
Anti-HEL Ig Transgenic B Cells Rapidly Proliferate at the Perimeter of Follicles
We next considered that the rapid proliferative response of pre-GC B cells at the perimeter of follicles might only take place during immune responses to certain antigens. To investigate this possibility, we injected B cells expressing a transgene-encoded BCR specific for hen egg lysozyme (HEL) into immunosufficient, nonirradiated, nontransgenic, syngeneic recipients either primed 3 days earlier with HEL in alum i.p. or 12 hr after cell transfer. Results analogous to those obtained with the HKI65/Ars system were found in this study ( Figure 6 ). Specifically, at days 2 and 3 of the response in the preimmunization protocol ( Figure 6A , left and center panels) and day 6 of the postimmunization protocol ( Figure 6B , right panels), the majority of donor (IgM a+ ) B cells and were located at the perimeter of follicles. By day 4 of the preimmunization protocol and day 7 of the postimmunization protocol, many of these donor B cells were becoming GL7 + and had entered or formed GCs ( Figure 6A , lower-right panel and Figure 6B , day 7). Detailed staining analysis of the GCs obtained with the postimmunization protocol showed that they contained a low frequency of CD4 + T cells ( Figure 6B , day 7) and extensive FDC networks ( Figure 6B , right, bottom panels). Flow cytometric studies using CFSE-labeled anti-HEL B cells revealed that at the time points at which such cells Ars-KLH-primed recipient mice were injected with CFSE-labeled splenocytes from HKI65-Vk10 mice (as described in the legend to Figure 1 and Experimental Procedures) and sacrificed on day 3 after transfer. Spleen cells from the chimeric mice were stained with anti-B220 and GL7 Abs, and B cells in different CFSE dilution subpopulations were isolated by FACS (see plot on lower right were mainly located at the follicular perimeter, they had divided several times and were GL7 + (data not shown). Therefore, anti-HEL Ig transgenic B cells, like HKI65-Vk10 transgenic B cells, undergo rapid proliferation at the follicular perimeter prior to entering the GC reaction.
Location of Accessory Cells during Pre-GC B Cell
Proliferation at the Follicular Perimeter CD4 + T cells, FDCs, and certain subclasses of other dendritic cells (DCs) have all been shown to provide growth, survival, and differentiation signals to antigen-activated B cells (Clark and Lane, 1991; Berney et al., 1999; Tew et al., 2001; MacLennan et al., 2003; Haynes, 2008) . To determine whether any of these cell types were colocalized at the follicular perimeter during the height of the pre-GC B cell proliferative response there, we performed more extensive histological analyses by using the postimmunization protocol. CD11c + interdigitating DCs were clearly absent from the follicular perimeter ( Figure 7A , left panels). Sparsely scattered T cells ( Figure 7A , right panels) and FDCs ( Figure 7B ) were found in this locale, but they did not appear to be directly associated with most donor B cells. Also, staining for the MZ B cell marker CD1d ( Figure 7C ) suggested that donor B cells had not acquired this phenotype. Analogous results were obtained with the preimmunization protocol (data not shown). These data revealed a scarcity of conventional accessory cells for follicular B cell differentiation and proliferation at the follicular perimeter.
DISCUSSION
The data presented here demonstrate that during the initial phases of GC B cell development, rapid proliferation takes place at the perimeter of follicles. Antigen-activated B cells in this locale
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The Site of Pre-GC B Cell Proliferation display a gene and cell-surface-antigen expression profile consistent with recent departure from the T cell zone (i.e., moderate CCR7 expression prior to proliferation) and ongoing development via the GC pathway (i.e., low to moderate AID, BCL-6, and GL7 expression and sIgD downregulation). Moreover, highly proliferative B cells in this locale express very low levels of RNA encoding CXCR4, CXCR5, and CCR7, indicating that they are not simply ''in transit'' from the T cell zone to the GC. The subsequent migration of large numbers these B cells to the center of the follicle in which they are resident suggests that GCs are initially formed by B cell coalescence, rather than proliferation in situ.
Our results support previous speculations (Jacob et al., 1993; McHeyzer-Williams et al., 1993 ) that SHM is not induced during the initial stages of GC B cell proliferation. Past studies on this issue were hampered by lack of knowledge of the time in which GC precursors entered the GC reaction and the degree to which these precursor clones had expanding prior to entry. More importantly, our data indicate that the majority of the ''mutation-free'' period of pre-GC B cell proliferation takes place at the perimeter of follicles. Very shortly after entering GCs, however, donor B cells in our experiments must have substantially upregulated SHM, given that the majority of the transgenic V H clones we isolated from microdissected GCs 5 days after cell transfer con- tained substantial numbers of somatic mutations. These data are incompatible with the idea that high-rate SHM occurs as a function of GC B cell division alone. In contrast, they support the notion that a B cell-extrinsic factor(s) present in the GC proper is required to promote this process. Our results demonstrating very low or undetectable heavy-chain class switching in B cells rapidly proliferating at the perimeter of follicles contrast with past findings also obtained with a transgenic B cell adoptive transfer approach. In these studies, a major fraction of donor B cells were found to have switched to IgG expression at the T-B interface and in the follicles of the spleen 4 days after immunization and to have undergone more extensive expansion than their IgM-expressing counterparts (Pape et al., 2003) . Another previous study suggested that the cytoplasmic tail of membrane IgG confers a proliferative advantage to responding B cells in the AFC pathway (Martin and Goodnow, 2002) . Nonetheless, our data demonstrate that expression of an IgG form of the BCR is not a prerequisite for the dramatic burst of proliferation characteristic of the early stages of pre-GC B cell development.
These considerations emphasize the importance of future studies to determine how changes in the many conditions known to affect the quantity and quality of B cell responses impinge upon proliferation and differentiation at the perimeter of follicles. For example, the response of most anti-HEL B cells in this locale was characterized by both rapid proliferation and induction of GL7 and PNA binding, both classical GC B cell markers. In contrast, the proliferative response of HKI65-Vk10 B cells in this locale was slower and accompanied by a more gradual induction of GL7, as well as reduction of IgD expression. It is tempting to speculate that variation in the affinity of the BCR(s) expressed by donor B cells for the driving antigen resulted in the differences in cellular behavior described here (e.g., the K a of the HKI65-Vk10 BCR for Ars is $2 3 10 5 (Rothstein et al., 1983) , whereas the K a of the anti-HEL BCR for HEL is >10 8 (Goodnow et al., 1988) and in previous studies. In total, our results demonstrate that a previously unrecognized microenvironment existing at the perimeter of follicles opposite the T cell zone can promote the initial proliferative stages of the GC B cell response, namely, after primary interaction with T cells at the interface of follicles and the T cell zone, and prior to formation of or entry into the GC. Although our studies were restricted to the spleen, others have observed antigen-specific B cell proliferation in the subcapsular perimeter of lymph node follicles after immunization with a TD antigen (Garside et al., 1998) and have described a unique class of antigen-transporting DCs that localize to this region of LNs shortly after immunization (Berney et al., 1999) . Future studies on the factors that regulate the migration of recently activated B cells to and retention and activity of pre-GC B cells in this microenvironment are clearly required.
What might be the function of this intermediate stage of rapid clonal expansion during TD B cell responses in which the structure and function of BCRs remain largely unaltered? In the context of natural infections, Cohn noted many years ago (Cohn, 1972 ) that unless a large pool of pathogen-specific lymphocytes was generated in a short period of time, the infec- tion would overwhelm the host as a result of the high replicative capacity of most pathogens. Since that time, numerous studies have shown that the GC reaction is an extremely dynamic process in which BCR structures are modified by SHM and CSR, and stringent selective forces are brought to bear on GC B cells on the basis of the affinity and specificity of their BCRs (Kelsoe and Zheng, 1993; MacLennan, 1994; Liu and Arpin, 1997; Camacho et al., 1998) . SHM alters the structure of antibody V regions rather randomly (Winter and Gearhart, 1998) , and for this reason the majority of somatic mutations are expected to disrupt expression of BCRs, or alter their affinity and specificity such that the GC B cells expressing them are counter selected (Shlomchik et al., 1989; Casson and Manser, 1995; Wiens et al., 1998) . Given such considerations, the average rate of SHM per GC B cell division has been argued to approach that which would prevent the clonal expansion of B cells during an immune response (Shlomchik et al., 1989) . This suggests that if individual GCs are founded by only small numbers of B cell precursors, subsequent generation of effector populations of sufficient size, expressing BCRs of the affinity and specificity necessary for rapid antigen (pathogen) clearance, might not occur. Therefore, proliferation of pre-GC B cells at the perimeter of the follicle may allow nucleation of the GC reaction by antigen-specific clones large enough to ensure a productive outcome of the subsequent GC response. This scenario would not be inconsistent with the fact that the GC reaction is oligoclonal (Kroese et al., 1987; Jacob et al., 1991; Liu et al., 1991) if the number of B cell precursors to the proliferative phase of the response at the follicular perimeter was limited or if affinity and specificity-based clonal selection took place in this microenvironment.
Limited CSR during this phase of the response may serve a similar function. As discussed above, IgG forms of the BCR appear to have enhanced ability to stimulate proliferation as compared to IgM and IgD forms (Martin and Goodnow, 2002; Pape et al., 2003) . Therefore, CSR to IgG isotypes could interfere with the clonal selection of GC B cells that have increased affinity and that are specific for the driving antigen as a result of SHM. Moreover, delaying the irreversible decision regarding which of the H chain isotypes to express as secreted antibody until after the mutation-selection process is well underway may maximize the probability that highly specific antibodies with effector functions most suited to the nature of the infecting pathogen are generated during TD immune responses. Testing these ideas will require the development of experimental approaches that selectively perturb the migration to and proliferation of B cells at the perimeter of follicles. In this regard, chemokine receptors expressed by responding B cells seem particularly obvious targets. Indeed, Cyster and colleagues (Reif et al., 2002) have observed lodging of CCR7-deficient anti-HEL transgenic B cells at the follicular perimeter after transfer into HEL immunized, CCR7-sufficient recipient mice.
In total, the data we present reveal a previously unappreciated stage of memory B cell development in which rapid clonal expansion takes place in the absence of differentiation at the perimeter of follicles. We suggest that this proliferative phase provides a precursor population for the GC reaction of sufficient size to ensure the subsequent development of the memory B cell compartment. These findings necessitate revision of current models of the TD B cell immune response.
EXPERIMENTAL PROCEDURES
Mice HKI65 V H mice have been previously described (Heltemes-Harris et al., 2004) . To produce the double-transgenic HKI65-Vk10 mouse line, we bred HKI65 mice to a line of conventional Vk10A light-chain transgenic mice termed Vk1060 (a kind gift of L. Wysocki). Vk1060 transgenic mice bear a functional Vk10A-Jk1 gene encoding the light chain of canonical Ars antibodies. Tg(IghelMD4)4Ccg/J mice were purchased from the Jackson Laboratory (Bar Harbor, ME, USA). C57BL/6 and B6.SJL-Ptprca Pepcb/BoyJ (B6.CD45.1) mice were originally obtained from the Jackson Laboratory and were bred in house. Mice were housed under pathogen-free conditions and were given autoclaved food and water. The use of mice in these studies was approved by the university's institutional animal care and use committee.
Adoptive Transfers and Immunizations B cells were enriched from HKI65-Vk10 or Tg(IghelMD4)4Ccg/J spleens via anti-CD4, anti-CD8 and anti-Thy1.2 and C-mediated lysis. Alternatively, non-B cells were depleted by incubation with biotinylated anti-CD3, anti-Thy1.2 and anti-CD11b (Mac-1), or anti-CD43 followed by MACS (Milteny Biotec, Auburn, CA, USA). In some experiments, enriched B cells were labeled with CFSE (Molecular Probes, Eugene, OR, USA) as previously described (Lyons and Parish, 1994) . B cells (2 3 10 4 to 2 3 10 7 ) were injected into the tail vein or retro-orbital sinus of syngeneic recipients. Three immunization protocols were used. Recipient mice were either injected with donor cells and immunized 12 hr later with 100 mg of Ars-KLH (or HEL) in alum i.p. (postimmunization protocol) or received 100 mg of Ars-KLH (or HEL) in alum i.p. 1 week or 3 days before cell transfer with an additional injection of 50 mg of Ars-KLH (or HEL) in PBS i.p. at the time of adoptive transfer (preimmunization protocols).
Immunofluorescence Spleens were snap frozen in OCT compound and cryosections (5-6 mm) made as previously described (Vora et al., 1998) . Immunofluorescence staining was also performed as previously described (Heltemes-Harris et al., 2004) . The following mAbs and reagents were used: E4-biotin, 5Ci-biotin (both made in house), anti-CD1d-biotin, and anti-TCRb (H57-597)-biotin (both from BD Biosciences) and then SA-PE (Molecular Probes) or SA-Alexa 633 (Molecular Probes); rat anti-CD169 (MOMA1) (Serotec, Raleigh, NC, USA), rat anti-mouse (Vora et al., 1998) . BrdU detection was done as described in the kit manual. Alternatively, BrdU-labeled cells were revealed with rat BrdU antibodies (Serotec) and then mouse anti-rat IgG-AP (Jackson Immunoresearch Laboratories).
Flow Cytometry
Single-cell suspensions were prepared and stained with combinations of the following Abs and reagents: E4-biotin (made in house), PNA-biotin (Vector Laboratories), GL7, anti-B220 (RA3-6B2)-PE, anti-CD45.2 (104)-PE, anti-CD138 (281.2)-PE (all from BD Biosciences), anti-CD45.2-PE and biotin (eBiosciences), anti-IgD (11-26)-PE (Southern Biotech, Birmingham, AL), and anti-mouse IgG-biotin (Jackson Immunoresearch). Staining with GL7 was followed by staining with biotin-mouse anti-rat IgG (Jackson Immunoresearch Laboratories). Whole-mouse Ig (Jackson Immunoresearch Laboratories) was used for blocking Fc receptors. CyChrome-SA (BD Biosciences), SA-PerCPCy5.5, or SA-PE-Cy5.5 (both from eBioscience) were used for detecting biotinylated Abs and other reagents. Cells were either sorted immediately with an EPICS Elite-ESP or a MoFlo high-performance cell sorter (DakoCytomation) or analyzed on an EPICS XL-MCL (Coulter, Hialeah, FL, USA). If not analyzed immediately, cells were fixed in 2% formaldehyde. Data were analyzed with the FLOWJO software (Treestar, San Carlos, CA, USA).
Molecular Genetics
B cells in peaks of CFSE fluorescence intensity corresponding to different cell divisions were sorted into 13 PBS. Genomic DNA was isolated with the DNeasy Blood & Tissue Kit (QIAGEN). For laser capture microdissection of GCs, frozen spleen sections (7-8 mm) were mounted on PEN-Membrane slides (Leica) and immunohistochemistry was performed as previously described (Vora et al., 1998) . In brief, sections were labeled sequentially with anti-CD45.2 (104)-biotin (eBioscience), SA-AP (Vector), and PNA-HRP (Sigma). Slides were developed with the Alkaline Phosphatase Substrate Kit III and NovaRed Substrate kit for peroxidase (both from Vector). Tissue from individual PNA + , CD45.2 + GCs was microdissected with the LMD6000 laser microdissection system (Leica), and genomic DNA was released by Proteinase K treatment. The HKI65 V H locus was amplified via nested PCR performed on DNA from sorted cells and microdissected tissue samples with Pfx50 DNA polymerase (Invitrogen). A first round of 35 cycles was performed with the primers 5 0 -CAACCTATGATCAGTGTCCTC-3 0 (hybridizing 5 0 of the leader exon) and 5 0 -GGACTCCACCAACACCATCAC-3 0 (hybridizing to the J H 2-J H 3 intron).
A small aliquot of the first round was amplified an additional 32 cycles with the primers 5 0 -CAGGTGTCCACTCTGAGGTTC-3 0 (hybridizing to the end of the leader exon and the beginning of the HKI65 V H locus) and 5 0 -GTGTCCCTA GTCCTTCATGACC-3 0 (hybridizing to the J H 2-J H 3 intron 5 0 to the first-round reverse primer). PCR products of the expected size were cloned into plasmid vectors, sequenced at the Kimmel Cancer Center Nucleic Acids Facility and analyzed with CLUSTALW multiple sequence alignment program. RNA from sorted cells was extracted with the RNeasy mini kit (QIAGEN), according to the manufacturer's instructions and first-strand cDNA was synthesized with TaqMan reverse transcription reagents (Applied Biosystems, Foster City, CA, USA). Quantitative real-time RT-PCR was performed with the following gene expression assays: Mm 99999055_m1 (Cxcr4), Mm00432086 (Blr1), Mm01301785_m1 (Ccr7), Mm00507774_m1 (Aicda), Mm01703609_g1 (Ighg), Mm00477633_m1 (Bcl6), Mm00476128 (Prdm1), Mm99999915_g1 (Gapdh), and universal master mix (Applied Biosystems). Data were collected with the ABI Prism 7000 sequence detection system (Abbott Diagnostics). Individual gene expression was normalized to GAPDH.
Statistical Analysis
Statistical significance was determined with two-tailed, unpaired Student's t test in the Microsoft Excel program.
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